Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Stocks | 97.240 | 97.240 | 0.000 |
Other | 2.760 | 2.760 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.686 | 16.306 |
Price to Book | 2.017 | 2.132 |
Price to Sales | 1.313 | 1.512 |
Price to Cash Flow | 9.605 | 8.567 |
Dividend Yield | 3.154 | 2.516 |
5 Years Earnings Growth | 7.331 | 13.599 |
Name | Net % | Category Average |
---|---|---|
Industrials | 27.790 | 28.741 |
Healthcare | 27.340 | 28.354 |
Financial Services | 17.940 | 17.630 |
Consumer Cyclical | 7.300 | 4.984 |
Basic Materials | 5.470 | 4.560 |
Technology | 5.000 | 6.380 |
Consumer Defensive | 4.740 | 7.562 |
Utilities | 4.410 | 4.516 |
Number of long holdings: 37
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 8.12 | 850.6 | -2.58% | |
Danske Bank | DK0010274414 | 7.64 | 193.7 | -4.61% | |
Vestas Wind | DK0061539921 | 5.46 | 180.8 | +0.86% | |
Pandora | DK0060252690 | 5.32 | 1,119.5 | -2.61% | |
DSV | DK0060079531 | 5.22 | 982.8 | +0.06% | |
Novozymes B | DK0060336014 | 5.11 | 412.2 | +5.88% | |
Carlsberg B | DK0010181759 | 4.61 | 928.0 | +0.32% | |
Oersted AS | DK0060094928 | 4.29 | 406.40 | +3.73% | |
ISS A/S | DK0060542181 | 4.24 | 122.30 | -0.41% | |
Coloplast | DK0060448595 | 4.21 | 860.0 | +2.23% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
PFA Invest Balance B | 6.3B | 6.62 | 4.62 | 6.58 | ||
PFA Invest Balance A | 3.42B | 1.61 | 0.71 | 3.67 | ||
PFA Invest Globale Aktier | 3.79B | 11.67 | 10.12 | 10.82 | ||
PFA Invest Balance C | 2.33B | 4.92 | 7.05 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review